Clinical Trials in Cancer: Principles and Practice (Oxford Medical Publications)

David J Girling (, formerly Senior Scientist, Cancer Division, Medical Research Council Clinical Trials Unit, London, UK)

ISBN 10: 019262959X / ISBN 13: 9780192629593

Published by Oxford University Press, United Kingdom, Oxford, 2003

About this Item

Clinical Trials in Cancer provides concise, accessible and practical information on the practicalities of planning, designing, conducting, analysing, reporting, and interpreting phase III clinical trials predominantly, but also single-arm and randomized phase II trials. The book shows clearly how recent developments and current thinking can be implemented. Information on the need to decide and measure realistic target differences in trials, the conduct and interpretation of interim analyses, patient advocacy, good clinical practice, the study of quality of life, the role of meta-analyses, and informed consent and other ethical issues are also covered. This book will prove invaluable for medical, statistical, and biological cancer researchers, health care professionals, and researchers in the pharmaceutical industry. Trial sponsors, principal investigators, members of data monitoring and trial supervisory committees, specialists invited to provide independent assessments, and many others involved in all aspects of research related to clinical trials should also find this book helpful. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.

Seller Inventory # GOR008101196

Bibliographic Details

• Title: Clinical Trials in Cancer: Principles and Practice (Oxford Medical Publications)
• Publisher: Oxford University Press, United Kingdom, Oxford
• Publication Date: 2003
• Language: English
• ISBN 10: 019262959X
• ISBN 13: 9780192629593
• Binding: Paperback
• Condition: Very Good
• Weight: 839 grams

About this title

Synopsis

Clinical Trials in Cancer provides concise, accessible and practical information on the practicalities of planning, designing, conducting, analysing, reporting, and interpreting phase III clinical trials predominantly, but also single-arm and randomized phase II trials. The book shows clearly how recent developments and current thinking can be implemented. Information on the need to decide and measure realistic target differences in trials, the conduct and interpretation of interim analyses, patient advocacy, good clinical practice, the study of quality of life, the role of meta-analyses, and informed consent and other ethical issues are also covered.
This book will prove invaluable for medical, statistical, and biological cancer researchers, health care professionals, and researchers in the pharmaceutical industry. Trial sponsors, principal investigators, members of data monitoring and trial supervisory committees, specialists invited to provide independent assessments, and many others involved in all aspects of research related to clinical trials should also find this book helpful.

About the Author

David J Girling, Senior Scientist, Cancer Division, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK Mahesh K B Parmar, Head, Cancer Divsion, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK Sally P Stenning, Senior Medical Statistician, Cancer Division, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK Richard J Stephens, Research Scientist, Cancer Division, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK Lesley A Stewart, Head of Meta-analysis Group, Cancer Division, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK